Risk and timing of cardiovascular death among patients with myelodysplastic syndromes

Myelodysplastic syndromes (MDS) are clonal hematopoietic stem cell disorders associated with progression to leukemia and poor survival. Clonal hematopoiesis in people without an MDS diagnosis carries an increased risk of cardiovascular death. Many clonally restricted mutations are shared between pat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Blood Adv
Autors principals: Brunner, Andrew M., Blonquist, Traci M., Hobbs, Gabriela S., Amrein, Philip C., Neuberg, Donna S., Steensma, David P., Abel, Gregory A., Fathi, Amir T.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2017
Matèries:
Myeloid Neoplasia
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5728287/
https://ncbi.nlm.nih.gov/pubmed/29296849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2017010165
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars